Clinical Trial Update: Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome.

View source ↗

Summary

A clinical trial update indicates enrollment is ongoing for a study evaluating a novel biomarker combination to differentiate inflammatory bowel disease from ir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Irritable Bowel Syndrome

Snippet

Sponsor: DiaSorin Inc. | Conditions: IBD (Inflammatory Bowel Disease), IBS (Irritable Bowel Syndrome) | Status: ENROLLING_BY_INVITATION